
The biotech industry is experiencing strong growth and expansion amid increasing investments, robust demand, and a boosting IPO market. Also, the recently announced Fed rate cuts will benefit the market operations.
Amid this backdrop, investors could consider investing in solid small-cap biotech stocks BioCryst Pharmaceuticals, Inc. (BCRX), Harmony Biosciences Holdings, Inc. (HRMY), and Entrada Therapeutics, Inc. (TRDA) for significant upside.